x
Elara Pharmaceuticals Ltd - Logo
[contact-form-7 404 "Not Found"]

  • The Barn Holly Berry House Rough Park,
    Hamstall Ridware, Rugeley, Staffordshire, WS15 3SQ
  • 666-888-0000
  • info@elarapharma.com
Elara Pharmaceuticals Ltd - Logo
  • info@elarapharma.com
  • The Barn Holly Berry House Rough Park,
    Hamstall Ridware, Rugeley, Staffordshire, WS15 3SQ
  • Contact Us
  • Home
  • About Us
  • Our Business
  • Our Technology
  • Real World Data
  • News
    • In The News
    • Publications
  • Careers
Logo

Contact Info

  • The Barn Holly Berry House Rough Park,
    Hamstall Ridware, Rugeley, Staffordshire, WS15 3SQ
  • +44 20 8040 0302
  • info@elarapharma.com

Alzheimer’s Association International Conference (AAIC) 2022

Study of the Mechanism of Action of Blarcamesine (ANAVEX®2-73): Whole Blood Transcriptomics Analysis (RNAseq)
Identifies Treatment Impact on Compensatory Pathways by Restoring Key Neurodegenerative Pathways Functionality,
including Alzheimer’s and Parkinson’s Disease Pathways.

C. Williams (1), M. Kindermans (1) , F. Parmentier (1), F. Goodsaid (1), E. Hammond (2), C. Missling (2), M. Afshar (1)

(1)-Elara Pharmaceuticals Ltd, Paris, France, (2)-Anavex Life Sciences, New York, NY, USA

Publication

Elara Pharmaceuticals Ltd, The AI DRUG Development Company

  • The Barn Holly Berry House Rough Park,
    Hamstall Ridware, Rugeley, Staffordshire, WS15 3SQ
  • Call Us: +44 20 8040 0302
  • info@elarapharma.com

Menu

  • About Us
  • Our business
  • Technology
  • In The News
  • Contact Us

Subscribe

Keep in touch and subscribe to our latest news

    Elara Pharmaceuticals Ltd © 2024 All Rights Reserved